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Abstract
  As squamous  cell carcinoma is the predominant type of oral malignancy , 
therefore methods to prevent, detect or treat it in the best way is constantly being 
searched for.Biomarkers are  such agents which reveal genetic & molecular changes 
related to various endpoints of oral carcinogesis & thereby refine our ability of   
predicting it's biological course.They will refine our ability in allowing to predict the 
biologic course of oral cancer and thereby distinguishing individuals at high and or 
low risk of oral cancer development.Chemopreventives are agents whose curative 
capacity is defined with help of biomarkers so as to determine their effectiveness & 
safety.
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Introduction division and the evolution of those cells 
by natural selection in the body. The  predominant  type  of  cancer 
found  in  the  oral  cavity  is  squamous  cell  Genes which regulate cell growth 
carcinoma.  Carcinogenesis  is  a  process  by  and differentiation must be altered and   
which  normal  cells  are  transformed  into  genetic changes can occur at many levels, 
cancer  cells  and    is  characterized  by  a  from gain or loss of entire chromosomes 
progression  of  changes  on  cellular  and  to  a  mutation  affecting  a  single  DNA 
genetic level that ultimately reprogram a cell  nucleotide.  Two  broad  categories  of 
to  undergo  uncontrolled  cell  division,  genes  which  are  affected  by  these 
thus  forming  a  malignant  mass.  changes are-
Mutations in DNA that lead to cancer  1)  Oncogenes,  which    may  be  normal 
(only  certain  mutations  can  lead  to  genes  expressed at inappropriately high 
cancer  and  the  majority  of  potential  levels, or altered genes which have novel 
mutations will have no bearing) disrupt  properties and therefore, promotes the 
these orderly processes by disrupting the  malignant phenotype of cancer cells. 
p r o g r a m m i n g   r e g u l a t i n g   t h e  
2)  Tumor  suppressor  genes  are  genes  processes.Carcinogenesis is,thus, caused 
which inhibit cell division, survival, or  by this mutation of the genetic material 
other properties of cancer cells. Tumor  of normal cells, which upsets the normal 
suppressor  genes  are  often  disabled  by  balance  between  proliferation  and  cell 
cancer-promoting genetic changes. death. This results in uncontrolled cell Fig-1 :Cancers are caused by a series of  mutations.
Each mutation alters the behavior of  the cell somewhat.
Roles of Cellular Biomarkers Biomarkers help in the evaluation of  (A) Indicators of DNA repair mechanisms. prevention  or  use  of  therapies  and  the 
(B) Indicators of PCD  detection  of  the  earliest  stages  of  oral 
(C) Indicators of Tumor development &  mucosal  malignant  transformation. 
growth Biomarkers reveal the genetic and molecular 
(D) Indicators of genetic markers of oral  changes related to early, intermediate, and late 
cancer end-points  in  the  process  of   oral 
(A) Indicators of DNA Repair  carcinogenesis. These markers will refine our 
Mechanisms ability  in  allowing  to  predict  the  biologic 
Programmed cell death functions not  course  of  oral  cancer  and  thereby 
by  itself  but  in  concert  with  systems  that  distinguishing individuals at high and or low 
produce  DNA  repair.  Present  evidence  risk of oral cancer development. Genetic and 
indicates that cancer cells require a high level  molecular biomarkers will also determine the 
of  DNA  repair.  In  general,  these  include  effectiveness  and  safety  of   chemo 
repair of the telomeric ends of chromosomes  preventives. Biomarkers will also reduce the 
produced through the action of telomerase,  number of patients and the time for long-
and  repair  of  nucleotide  sequences,  term follow-up required to define a significant 
exemplified  by  mismatch  repair,  and  clinical response to a chemo preventive agent, 
nucleotide  excision  repair.  Telomeres  are  thereby  clarifying  the  types,  doses, 
heterochromatic  structures  at  the  ends  of  frequencies,  and  regimens  to  achieve  the 
eukaryotic  chromosomes  and  consist  of  maximum  level  of  benefit  from  chemo 
simple,  highly  conserved,  repeated  DNA  preventives.  This  review  will  focus  on  the 
sequences  (e.g.,  TTAGGG,  as  observed  in  development  of  genetic  and  molecular 
humans  and  mice).  Every  species  has  a  biomarkers, and the use of chemopreventives 
. 2 characteristic average of telomeric subunits.  to intervene in the oral carcinogenesis process
In  human  oral  carcinomas,  telomerase  is 
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clones by altering the numbers and types of  elevated  in  the  proliferative  areas  of  the 
cells in a tumor. The surviving transforming  carcinoma.  Defective  repair  processes  and 
cells appear to have suppressed PCD, and they  checkpoints are also linked to cancer genomic 
have a high rate of proliferation, enhanced  instability. The types of genomic instability 
levels  of  resistance  to  different  anti-tumor  seen in most cases of sporadic cancer suggest 
a  commonality  of  break  types  and  DNA  therapies, and elevated levels of DNA repair. 
repair  processes.  Examples  of  the  more  There are numerous genetic and molecular 
3 common  DNA  repair  sites  are  the  changes that are used to identify PCD. 
approximately 20 genes known to be involved 
in the process of nucleotide excision repair 
(NER)  or  the  repair/transcription  factors, 
such  as  TFIIH,  that  are  required  to 
orchestrate  the  function  of  incisional 
proteins, i.e., DNA polymerases, and ligases. 
These  changes  may  become  additional 
markers  for  the  aggressive  and  metastatic 
characteristics of oral carcinoma. DNA repair 
influences  the  progression  of   oral 
carcinogenesis  through  the  regulation  of 
various  growth  factors-  for  example, 
transforming  growth  factor,  TGF-3.  The 
development of a DNA repair defect and the 
presentation of a mutated TGF-3 receptor 
gene (e.g., glutamine and proline replaces a 
glutamic  acid  and  arginine)  have  been 
.1 considered to promote oral carcinogenesis
(B) Indicators of PCD (Programmed Cell 
Death)
There is a considerable body of work 
that  has  identified  several  hundred  cellular 
changes  or  biomarkers  associated  with  the 
growth of oral carcinoma and carcinomas of 
the  aero-digestive  tract.  Many  of  these 
indicators are also markers for programmed 
cell  death  (PCD).  PCD,  or  gene  directed 
apoptosis, is a common means used in nature 
to remove unwanted cells. It is characterized 
by  the  lack  of  an  inflammation-driven 
necrosis  of  the  tissue  and  the  histologic 
appearance of apoptotic cells. PCD is also an 
important  feature  of  oral  keratinocytes 
undergoing differentiation or transformation 
during oral cancer development. PCD may 
also play an important screening role in cancer 
formation. PCD results in the modification of 
the surviving cell population in transforming  Fig-2 : Steps of   CarcinogenesisChemopreventives and PCD:- 
The  treatment  with  chemo 
preventives, during malignant transformation 
or  in  fully  transformed  malignant  oral 
mucosal cells, results in the induction of PCD 
and  the  observed  inhibition  of  oral 
carcinogenesis and malignant tumor growth. 
Chemo preventives induce PCD because of 
their oxygen-responsive characteristics, which 
trigger inducers such as the tumor suppressor 
gene p53, modifiers of PCD such as the bcl-2 
family,  and  immune-derived  cytokines-for 
example,  TNF  Chemopreventives,  as   
exemplified  by  retinoids,  carotenoids, 
tocopherols,  bioflavonoids,  isothiocyanates, 
8 indoles, and polyphenols, induce PCD. 
C)Indicators of  Tumor Development & 
Growth
Biomarkers establish the level of risk 
for individuals in a cohort or target group of 
patients, and they may provide information 
concerning the etiology and the process of 
carcinogenesis. The primary goal for the use 
of early, intermediate, and late biomarkers is 
1,6 to identify individuals and their level of risk. 
(D) Indicators of Genetic Markers of Oral 
Cancer
A  developing  solid  clone  of  
transforming cells found in an oral carcinoma 
arrives  at  the  state  of  malignancy  by 
proceeding through stages of transformation. 
The transformation rate is dependent on the 
location of the clone in the spherical tumor  Oxidation and The Effect on PCD : -  7 mass and the oxygen states of the cells. 
Oral malignant transformation could 
Chemopreventive be a product of oxidative state change. The 
oxidative state change would then result in  Chemopreventives are chemicals of 
changes  in  DNA  repair  and  PCD.  The  natural or synthetic origin. Unlike other drugs, 
observed  cellular  manifestations  of  these  which  do  not  prevent  disease,  chemo                         
processes are losses of cell growth control  preventives reduce the incidence of diseases 
and  modifications  in  cell-cell  interactions,  such  as  cancer  before  clinical  symptoms 
which could enhance the potential for tumor  occur.  This  development  is  critical  for  the 
metastases.  Nutrients  that  act  as  understanding  of  early  oral  mucosal 
chemopreventives alter the oxidative state of  transformation.
the  oral  transforming  cell  by  acting  as 
(A) Overview reducing  agents  (e.g.,  anti-oxidant)  and/or 
oxidizing agents (e.g., pro-oxidant). A  concept  common  to  chemo 
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Fig-3 : When normal cells are damaged beyond repair, they 
are  eliminated  by  apoptosis  (A).  Cancer  cells  avoid 
apoptosis  and  continue  to  multiply  in  an  unregulated 
manner (B).  297 Oral Carcinogensis And Its Prevention
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prevention is the ability of chemical agents to  as äë-alpha tocopherol (vitamin E), are strong 
function as reducing agents, anti-oxidants, or  antioxidants  that  enhance  the  cellular 
oxidizing agents (pro-oxidants). The chemical  detoxification system by increasing the levels 
character of the chemopreventive will depend  of  glutathione-S-transferases  (Phase  II 
on the partial pressure of oxygen and the level  enzymes). The activation of these enzymes 
of oxidative metabolites produced or derived  may  also  lead  to  the  trapping  of  reactive 
in the cell. carcinogen metabolites or the triggering of 
apoptosis. â carotene, a carotenoid, acts as an 
anti-oxidant but can also act as a pro-oxidant,  Some  chemopreventives  may 
depending on the oxygen state of the cell. â - suppress  the  promotion  of  cancer  and 
carotene as well as ellagic acid (from garlic) are  prevent the transformation of pre-malignant 
carcinogen-blocking  agents  that  either  cells by altering differentiation. For example, 
suppress promotion or act as anti-oxidants,  retinoids  enhance  differentiation  while 
which  are  reducing  agents.  Their  specific  affecting housekeeping genes and oncogene 
mechanism  of  action  is  unknown,  but  expression. 
blocking  agents  prevent  carcinogenic  Another class of chemopreventives,  compounds from reacting with critical target  the  terpenes,  may  also  inhibit  oncogenic  sites  of  DNA  by  inhibiting  the  metabolic  expression  and  cell  proliferation,  reducing  activation  of  carcinogens  catalyzed  by  dedifferentiation. cytochrome P450 (Phase I enzymes). 
Indomethacin, an anti-inflammatory  Other chemopreventive agents, such  drug,  blocks  prostaglandin  synthesis  and 
Fig-4 : Many tumor suppressor genes effect signal transduction pathways which regulate apoptosis,
 also known as "programmed cell death  298 Oral Carcinogensis And Its Prevention
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reduces  tumor  development,  resulting  in  a  metabolite  which  can  undergo  further 
oxidation.  These  oxygenreactive  molecules  normal differentiation pattern.
could enhance genetic instability and result in 
Cells  also  protect  themselves  from  abnormal cell growth, differentiation, and cell - 
reactive  oxygen  substances  (ROSs)  by  cell interactions In cells, retinol and retinoic 
activating  anti-oxidant  pathways  and  acid  bind  to  specific  cytoplasmic  binding 
molecular  systems  that  use  enzymes.  proteins,  which  include  CRABP-I/II 
Examples  are  superoxide  dismutase,  which  (cytoplasmic retinol binding proteins I and II). 
controls the level of the superoxide anion (e.g.,  The cellular binding proteins mediate transfer 
0 -)' whereas catalase modifies the levels of  2 of retinol and retinoic acid from the cytoplasm 
hydroxyl radicals (e.g., OH-), and glutathione-  to  the  nucleus.  The  nuclear  retinoic  acid 
S-transferase  (GSTs)  alters  the  level  of  the  receptors (RAR) are members of the steroid-
intracellular anti-oxidant glutathione. thyroid  superfamily  of  nuclear  receptors. 
Retinoid modulation of gene expression is the  Less obvious cellular anti-oxidants are 
result of the activation of one of four possible  proteins such as Bcl-2, which is comprised of a 
receptors.  The  RARs  are  found  in  many  family of proteins that modifies PCD. 
different isoforms, as shown by mRNA, which 
There are also several protein families  indicates that the isoforms arise from different 
that  function  as  redox,  anti-oxidant/pro- promoters or by alternative RNA splicing in a 
oxidant molecules that also regulate PCD (e.g.,  region at the 5' end of the mRNA. Isoforms 
p53). Perhaps the most important common  appear  to  be  tissue-specific,  and  their 
feature of chemopreventives is their ability to  expression  is  stage-specific,  suggesting 
trigger  PCD  in  transformed  cells.  The  distinctive  roles  for  each  isoform.  The 
retinoids,  carotenoids,  tocopherols,  expression of mRNA for RAR-, -â, -ã, and -x 
isothiocyanates, and polyphenols induce PCD  has been found in normal oral mucosa. The 
in  various  cell  types.  Clinically,  there  is  an  development  of  premalignant  change  and 
advantage  to  the  combination  of   smoking  or  alcohol  use  do  not  appear  to 
chemopreventives  with  chemotherapeutics,  change  the  general  distribution  of  these 
8 especiallywith the alkylating agents.  receptors  in  oral  tissue.  However,  recent 
studies  have  indicated  that  with  retinoid  (B) Genetic, molecular, and biochemical  treatment there is an increase in the level of  activities of chemopreventives RAR-â in pre-malignant lesions. Lotan et al.  (I) Retinoid Chemopreventives:-  (1995) presented a study where RAR-1 was 
depressed  during  pre-malignant  change  and  The retinoid molecule family consists 
retinoid  treatment,  and  remission  of  oral  of vitamin A and its derivatives. The primary 
leukoplakia was coincident with an increase in  source of retinoids in the diet is retinyl esters 
RAR-â. It appears that RAR-â   may be an  from  animal  tissues  and  retinol  from  the 
important indicator for a retinoid response in  conversion  of  carotenoids  (e.g.,  3-carotene) 
premalignant or malignant oral mucosa. The  derived from a vegetable source. Retinol tends 
aberrant response to retinoic acid, as reflected  to be the biologically active form, but retinoic 
by  RAR-â  modulation,  is  also  echoed  by  acid  may  substitute  for  retinol  for  many 
changes  in  related  growth  factor  receptors  functions, and both can be found in the serum 
such  as  epidermal  growth  factor.  Retinoid  linked to proteins. Retinol binds to proteins 
ligand specificities are found in recombinant  designated as retinol-binding proteins, while 
RAR-á and RAR-â receptors, with at least two  retinoic acid is associated with albumin. The 
retinoid analogs binding preferentially to either  normal  plasma  level  for  retinol  is 
RAR-á or RAR-â. Initial studies suggested that  approximately  2  mmol/L,  while  that  of 
RAR-â  was  approximately  10-fold  more  retinoic acid is 10 to 20 nmol/L, about 150-
sensitive to all-trans retinoic acid than RAR-á.  fold  lower  than  retinol  Retinoic  acid  is 
The results of these studies indicated that the  metabolized  by  hydroxylation  of  the 
blockage of the RAR changed tissue oxidation  cyclohexenyl  ring,  a  reaction  mediated  by 
of retinol to retinoic acid, but other oxidation  cytochrome  P450,  producing  a  4-hydroxy   299 Oral Carcinogensis And Its Prevention
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processes, perhaps linked to cytochrome P450  cancers. These results again indicate that the 
activity, may also be altered. Recent studies  responses  of  tissues  to  retinoids  are  more 
have  also  indicated  that  the  conversion  of  complex than is apparent from studies that 
10,11 retinol to retinoic acid might be mediated by  emphasize RAR expression. 
the RAR. The ability of retinoids to inhibit or 
(ii)  Genetic  and  molecular  activities  of  increase the growth of cancer cells could be 
carotenoid and tocopherol:-  dependent on the accumulation and rates of 
conversion  and  non-conversion  of  retinoic  The  carotenoids  and  tocopherols 
acid in the cell. It is well-known that head and  produce  genetic  and  molecular  responses 
neck  squamous  cell  carcinoma  (HNSCC)  similar  to  those  observed  with  the 
patients,  particularly  those  who  smoke  retinoids.The specificities of these responses 
tobacco, have low levels of serum retinoids.  have been previously reviewed Animal studies 
Their low intake of fruits and vegetables may  with the hamster buccal pouch tumor model 
play a role in the development of oral cancer,  have  further  confirmed  some  of  the 
but the cellular state of the oral mucosa must  similarities  between  these  chemopreventive 
also be considered. The concentration of any  groups and the retinoids. These include the 
retinoid metabolite may be initially dependent  over-expression and halflife of p53, enhanced 
on the type, number, and affinity of the RARs  differentiation of the oral mucosa, reduction 
present on the cell. Changes in the binding and  in  neovascularization  of  developing  oral 
concentration  of  the  CRBP  (cytoplasmic  cancers, and the induction of apoptosis. The 
retinal binding protein) or CRABPs might also  major cellular differences between the retinoid 
influence  the  triggering  of  retinoic  acid  response and the carotenoids or tocopherols is 
response  elements  (RARE)  and  associated  the  lack  of  a  complex  receptor  system 
genes.  Exogenous  influences  affect  the  described above for the retinoids. In general, 
conversion  of  retinol  to  retinoic  acid  by  the major biochemical similarity among these 
altering the activity of alcohol dehydrogenase  groups  (e.g.,  carotenoids,  retinoids, 
and  the  cytrochrome  P450  system  noted  tocopherols) is their isoprenoid structure and 
above.In  addition,  retinoic  acid  receptors  biochemical  sterol  effects.  Their  sterol 
appear to be involved in the differentiation of  chemistry is derived from their hydrophobic 
myeloid cells and keratinocytes. Retinoic acid  cyclic  structures  that  contain  unsaturated 
binding to its receptors has also been shown to  double bonds.
induce  apoptosis  in  the  differentiating  cell 
9,10 Chemopreventives,  as  a  group,  population.
respond to changes in oxygen partial pressure 
The  finding  that  programmed  cell  that influences their ability to act as oxygen free 
death  occurred  following  treatment  with  radical  quenchers  or  reactive  oxygen 
1 3 retinoic  acid  indicates  that  a  cascade  of  molecules.   In  a  well-oxygenated 
definitive genetic changes was set into motion.  environment, thecarotenoid, â-carotene, can 
RA induction of PCD may be different from  inhibit the growth of oral cancer cells, because 
other chemopreventive inductions of PCD by  the carotenoid induces an oxidative stress in 
trig gering  BAG-1  and  inter nal  the tumor cell. At the identical partial pressure 
phosphorylation signals that trigger the Bcl-2  of oxygen, tocopherol tends to have an anti-
system of proteins. Other chemopreventives,  oxidant  activity  and  reduces  the  oxidative 
such as BC or vitamin E, appear to activate the  stress. These oxygen-handling characteristics 
oncogene-inductive process (e.g., p53) and/or  could affect the triggering of PCD, the cell 
the immune-inductive process (e.g., the tumor  cycle,  by  modifying  kinase  activities  and 
necrosis  factor  ITNFI  receptor  family,  eventually lead to an alteration in activities such 
FAS/FASL)  for  PCD.  Retinoid-induced  as c-fos and other cellular processes linked to 
genetic  changes  will  not  only  inhibit  the  differentiation or DNA repair. The responses 
growth  of  developing  cancer  cells  or  of the oral mucosal cells to nutritional agents 
established cancer but also possibly promote  such as retinoids, carotenoids, or tocopherols 
the  growth  of  pre-malignant  or  malignant  will  also  depend  on  the  degree  of   300 Oral Carcinogensis And Its Prevention
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transformation that has occurred in the cell.  primary  anti-oxidant  in  this  pathway  is 
Normal cells appear to react to these agents by  glutathione, which can react with electrophilic 
differentiating,  while  transforming  cells  or  sites  produced  on  a  carcinogen  molecule 
fully transformed cells may also differentiate,  through  the  action  of  cytochrome  P450 
but  they  continue  toward  programmed  cell  hydrolyses. Glutathione also acts to block the 
death. Some of the more common membrane- nucleophilic  attack  of  the  carcinogen  on 
related  responses  to  â-carotene  and/or  DNA.  Chemopreventive  agents,  such  as 
tocopherols are the reductions in membrane- glutathione, may also function by enhancing 
associated  enzymes  such  as  serine  and  the elimination of the genotoxic agent from 
threonine  kinases,  connexin  43,  and  a  the liver and other tissues. In these tissues, the 
reduction  in  ras  proteins.  Other  previously  hydroxylation of the cytochrome P450 system 
discussed proteins, such as proto-oncogenes c- and  mixed-function  oxidases  (MFO) 
fos, cmyb, N-myc, and the tumor suppressor  eventually  terminates  with  conjugates  of 
p53,  have  been  shown  to  be  affected  by  reduced protein salts containing glucuronate 
9 treatment with these chemopreventives. Stress  and sulfates. 
proteins,  acting  as  cellular  chaperonins,  can 
Unfortunately, the activation of this  complex to p53, and, following treatment of 
system by  the  chemopreventive  agents  may  oral carcinoma cells with   â -carotene, their 
also  increase  carcinogenesis  by  producing  levels of expression increase and affect the 
more highly electrophilic epoxides. The result  movement of proteins. In addition, growth 
could be the conversion of procarcinogens to  factors and immune regulatory factors such as 
their genotoxic form, which could generate  EGF and TGF-á have a reduced expression, 
oxygen  free  radicals.  Many  of   the  while TGF-â1 and TNF- á   expression are 
chemopreventives may work not only through  elevated  during  the  inhibition  of  oral 
this pathway but also by altering the level of  carcinogenesis. The EGFR's affinity, number, 
glutathione-S-transferases  (GSTs)  which  and protein expression were reduced following 
mediates  electrophile  scavenging.  The  â -carotene treatment and suppression of oral 
carotenoids,  tocopherols,  and  retinoids  all  cancer growth. Studies reveal the broad effects 
appear to be capable of modifying GSTs. The  of   â  -carotene  and  other  similar 
carotenoid,  â-carotene,  has  been  shown  to  chemopreventives on many different cellular 
depress  GST  levels,  while  other  functions.  Importantly,  the  carotenoids  and 
chemopreventives, such as alpha tocopherol  tocopherols  do  not  appear  to  produce  the 
acid succinate or dithiolthione oltipaz, elevate  toxicity  seen  with  retinoids,  but  their 
the level of GST.  effectiveness at preventing or reversing pre-
11, 14 malignant change is unclear.   Chemopreventives have been shown 
to inhibit both initiation and promotion during  (D)  Oxidative  biochemistry  of   oral  carcinogenesis.  The  inhibition  of  chemopreventives initiation  may  occur  by  preventing  the 
Chemopreventive  agents  can  be  carcinogen  from  becoming  fully  active  by 
defined by their suppression or blocking of  enhancing DNA repair and/or the activation 
mutagenic  activity,  initiation,  and/or  of tumor suppressor genes. The inhibition of 
promotion during oral carcinogenesis. Agents  promotion  could  result  by  triggering 
that alter the mutagenic process are generally  differentiation. Initiation and promotion may 
enzymes  that  enhance  the  solubilization  or  also  be  affected  by  the  elimination  of 
degradation  of  mutagenic  or  carcinogenic  transformed  malignant  clones  of  cells.  The 
agents.  This  process  usually  activates  the  induction  of  an  inflammatory  cytotoxic 
intracellular anti-oxidant, glutathione, and its  immune  reaction  or  the  generation  of 
associated  system.  The  glutathione  pathway  apoptosis could accomplish this. Examples of 
regulates  free  radical  activity  by  producing  chemopreventives  that  have  exhibited  anti-
reducing  agents,  such  as  thiol-containing  promotional  activity  include  tamoxifen  (an 
proteins, with cysteine-glycine residues. The  anti-estrogen),  retinoids,  and  carotenoids,   301 Oral Carcinogensis And Its Prevention
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